View in EDS HTML Full Text PDF Full Text

Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.

Saved in:
Bibliographic Details
Title: Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.
Authors: Oura M; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Toho M; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Ikeda D; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Fukuda N; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Torres AS; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Fujii F; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Sakuma H; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Uehara A; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Tabata R; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Narita K; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Takeuchi M; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan., Matsue K; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Source: Frontiers in oncology [Front Oncol] 2026 Mar 12; Vol. 16, pp. 1738551. Date of Electronic Publication: 2026 Mar 12 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41907623
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oura+M%22">Oura M</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Toho+M%22">Toho M</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Ikeda+D%22">Ikeda D</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuda+N%22">Fukuda N</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Torres+AS%22">Torres AS</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Fujii+F%22">Fujii F</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Sakuma+H%22">Sakuma H</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Uehara+A%22">Uehara A</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Tabata+R%22">Tabata R</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Narita+K%22">Narita K</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Takeuchi+M%22">Takeuchi M</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Matsue+K%22">Matsue K</searchLink>; Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Mar 12; Vol. 16, pp. 1738551. <i>Date of Electronic Publication: </i>2026 Mar 12 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41907623
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1738551
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1738551
    Titles:
      – TitleFull: Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oura M
      – PersonEntity:
          Name:
            NameFull: Toho M
      – PersonEntity:
          Name:
            NameFull: Ikeda D
      – PersonEntity:
          Name:
            NameFull: Fukuda N
      – PersonEntity:
          Name:
            NameFull: Torres AS
      – PersonEntity:
          Name:
            NameFull: Fujii F
      – PersonEntity:
          Name:
            NameFull: Sakuma H
      – PersonEntity:
          Name:
            NameFull: Uehara A
      – PersonEntity:
          Name:
            NameFull: Tabata R
      – PersonEntity:
          Name:
            NameFull: Narita K
      – PersonEntity:
          Name:
            NameFull: Takeuchi M
      – PersonEntity:
          Name:
            NameFull: Matsue K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 03
              Text: 2026 Mar 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1